Communicating polygenic risk scores in the familial breast cancer clinic.
Guptaa KD, Gregory G, Meiser B, Kaur R, Scheepers-Joynt M, McInerny S, Taylor S, Barlow-Stewart K, Antill Y, Salmon L, Smyth C, McInerney-Leo A, Young MA, James PA, Yanes T.
Patient Educ Couns. 2020 Mar 1:S0738-3991(21)001683. doi: 10.1016/j.pec.2021.02.046. Epub ahead of print.
Interventions Facilitating Family Communication of Genetic Testing Results and Cascade Screening in Hereditary Breast/Ovarian Cancer or Lynch Syndrome: A Systematic Review and Meta-Analysis.
The role of the genetic testing industry in patient education of hereditary cancer: An observational study assessing the quality of patient education videos.
Greenberg DC, Kamara D, Tatsugawa Z, Mendoza M, Pineda E, Holschneider CH, Zakhour M.
Gynecol Oncol. 2021 Feb 19:S0090-8258(21)00150-5. doi: 10.1016/j.ygyno.2021.02.013. Epub ahead of print.
Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer.
Ripperger T, Evans D, Malkin D, Kratz CP.
Fam Cancer. 2021 Feb 12. doi: 10.1007/s10689-021-00228-2. Epub ahead of print.